UPC Analytics
ENDE
Overview · Filed:

UPC_APP_27016/2025

NOVEL LIPID FORMULATIONS FOR NUCLEIC ACID DELIVERY

Procedural & sub-applicationsCase Management OrdersThe Hague LDApplication Rop 333
  • 2025-06-12Procedural onlyproceduralApplication Rop 333

    The Hague Local Division issued a procedural order on a R. 333 RoP application by various Moderna entities (defendants) regarding service and deadlines for filing the Statement of Defence in infringement proceedings brought by Arbutus Biopharma and Genevant Sciences. The court denied requests to stay service or extend deadlines for individual defendants not yet formally served, while setting a single consolidated deadline for all Moderna group defendants to file one joint Statement of Defence.